We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+1.97%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$32.2B
AUM Growth
+$1.15B
Cap. Flow
+$886M
Cap. Flow %
2.75%
Top 10 Hldgs %
14.34%
Holding
3,060
New
26
Increased
2,469
Reduced
354
Closed
63

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$23.3M
2
XOM icon
ExxonMobil
XOM
+$22.8M
3
AAPL icon
Apple
AAPL
+$21.5M
4
WFC icon
Wells Fargo
WFC
+$19.8M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$17.3M

Sector Composition

Rank Sector Weight
1 Technology 14.4%
2 Financials 14.39%
3 Healthcare 13.67%
4 Industrials 10.84%
5 Consumer Discretionary 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TREC
2751
DELISTED
Trecora Resources
TREC
$188K ﹤0.01%
19,532
WLB
2752
DELISTED
Westmoreland Coal Company
WLB
$188K ﹤0.01%
26,078
+2,515
+11% +$15K
RGLS
2753
DELISTED
Regulus Therapeutics
RGLS
$187K ﹤0.01%
225
+1
+0.4% +$796
ARC
2754
DELISTED
ARC Document Solutions, Inc.
ARC
$187K ﹤0.01%
41,516
KODK icon
2755
Kodak
KODK
$874M
$186K ﹤0.01%
17,140
+700
+4% +$6.85K
PRTK
2756
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$186K ﹤0.01%
12,282
+65
+0.5% +$994
CLAR icon
2757
Clarus
CLAR
$127M
$185K ﹤0.01%
41,094
+5,088
+14% +$22.2K
ESCA icon
2758
Escalade
ESCA
$294M
$185K ﹤0.01%
15,740
+1,740
+12% +$21.5K
SQNM
2759
DELISTED
SEQUENOM INC NEW
SQNM
$183K ﹤0.01%
129,891
+1,900
+1% +$2.83K
OXFD
2760
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$182K ﹤0.01%
18,330
+110
+0.6% +$1.13K
ECYT
2761
DELISTED
Endocyte, Inc. Common Stock
ECYT
$182K ﹤0.01%
58,775
+5,310
+10% +$17.3K
VIVS
2762
VivoSim Labs
VIVS
$1.28M
$181K ﹤0.01%
348
IIP
2763
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
$180K ﹤0.01%
65,938
KVHI icon
2764
KVH Industries
KVHI
$179M
$179K ﹤0.01%
18,787
+380
+2% +$3.41K
REI icon
2765
Ring Energy
REI
$320M
$179K ﹤0.01%
35,463
+3,475
+11% +$17.3K
GIC icon
2766
Global Industrial
GIC
$1.39B
$178K ﹤0.01%
20,275
+1,575
+8% +$13.2K
DRRX
2767
DELISTED
DURECT Corp
DRRX
$177K ﹤0.01%
13,133
+1,220
+10% +$15.6K
IMUX icon
2768
Immunic
IMUX
$192M
$177K ﹤0.01%
49
+4
+9% +$13.9K
CUTR
2769
DELISTED
Cutera, Inc.
CUTR
$177K ﹤0.01%
15,771
+595
+4% +$6.75K
TTPH
2770
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$177K ﹤0.01%
1,913
+34
+2% +$3.4K
CRIS icon
2771
Curis
CRIS
$10M
$176K ﹤0.01%
55
+1
+2% +$3.37K
HCCI
2772
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$176K ﹤0.01%
17,752
+1,595
+10% +$14K
PETX
2773
DELISTED
Aratana Therapeutics, Inc.
PETX
$176K ﹤0.01%
31,874
+310
+1% +$1.17K
NVIV
2774
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$176K ﹤0.01%
1
B
2775
Barrick Mining
B
$64B
$175K ﹤0.01%
12,860

Similar funds

RhumbLine Advisers's Q1 2016 Portfolio in Review

As of Q1 2016, RhumbLine Advisers held 3,060 positions worth $32.2B, up 3.7% from $31.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q1 2016: portfolio turnover was 2.9%. RhumbLine Advisers opened 26 new positions and exited 63, leaving the 3,060-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2016 buy was Willis Towers Watson: 89,353 shares worth $10.6M.
  • RhumbLine Advisers added most to Broadcom in Q1 2016, an estimated $23.3M increase.
  • RhumbLine Advisers's biggest Q1 2016 reduction was Chubb, cutting an estimated $13.7M.
  • RhumbLine Advisers fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $43M.
  • RhumbLine Advisers's ten largest holdings make up 14% of its $32.2B portfolio in Q1 2016.
  • RhumbLine Advisers opened 26 new positions and closed 63 in Q1 2016.
  • RhumbLine Advisers's portfolio value rose 3.7% quarter-over-quarter to $32.2B.

Based on RhumbLine Advisers's 13F filing for Q1 2016, filed 2 May 2016.